J97-32314-28903
2 vaccinations
3 coded responses
16 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 794 / TX
- Registered
- 2021-01-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-08
Registered in v-safe
-
2021-01-08
Dose 1 — Pfizer-BioNTech
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
-
2021-01-28
Dose 2 — Pfizer-BioNTech
- 2021-02-05
- 2021-02-11
- 2021-02-20
-
2021-02-25
Survey response — day 28, dose 2MedDRA: Headache — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Head ache lasting over a weekMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-04
Survey response — day 35, dose 2MedDRA: Headache — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Continued headachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-31
-
2022-01-28
Survey response — 12 months, dose 2MedDRA: Ageusia, Anosmia, Dizziness, Dyspnoea, Nausea, Oropharyngeal pain, Pain, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: 1/17/22 tested positive for COVID-19. Fever, body aches, sore throat, runny nose, loss of taste and smell, dizziness, short of breath, nausea and vomiting.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Pfizer-BioNTech | |
| 2 | 2021-01-28 | Pfizer-BioNTech |
Free text
Release 4 — day 28, dose 2
Symptoms: Head ache lasting over a week
Release 5 — day 35, dose 2
Symptoms: Continued headaches
Release 11 — 12 months, dose 2
Symptoms: 1/17/22 tested positive for COVID-19. Fever, body aches, sore throat, runny nose, loss of taste and smell, dizziness, short of breath, nausea and vomiting.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release